China Pharma Holdings, Inc. (CPHI)
Chart Events
Performance Outlook
| Previous Close | 0.4865 |
| Open | 0.4865 |
| Bid | 0.4600 x 4000 |
| Ask | 0.4760 x 800 |
| Day's Range | 0.4600 - 0.4865 |
| 52 Week Range | 0.2200 - 1.4000 |
| Volume | 480,480 |
| Avg. Volume | 458,809 |
| Market Cap | 20.583M |
| Beta (5Y Monthly) | 0.45 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.4680 |
| Earnings Date | Nov 13, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3.00 |
Fair Value
Related Research
- PR Newswire
China Pharma Holdings, Inc. Reports Third Quarter 2020 Financial Results
China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced financial results for the quarter ended September 30, 2020.
- Simply Wall St.
A Quick Analysis On China Pharma Holdings' (NYSEMKT:CPHI) CEO Salary
This article will reflect on the compensation paid to Zhilin Li who has served as CEO of China Pharma Holdings, Inc...
- PR Newswire
China Pharmaceutical Holdings Co., Ltd. Has Obtained Multiple Certifications for Its Masks
China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced that the masks produced by its subsidiary Hainan Helpson Medicine & Biotechniqe Co., Ltd. has received multiple certifications, and have been listed on the Whitelist ("Whitelist" refers to the "List of Non-Medical Mask Manufacturers that have Obtained Foreign Standard Certification or Registration" and "List of Medical Material Production Enterprises that have Obtained Foreign Standard Certification or Registration" as indicated in document No. 12 issued by the Chinese government in 2020).
